Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics:  Structure and Degradation Pathways - Journal of Pharmaceutical Sciences

Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways - Journal of Pharmaceutical Sciences

4.6
(563)
Write Review
More
$ 33.00
Add to Cart
In stock
Description

FORMULATING PEPTIDES - Novel Formulations for Non-Invasive Delivery & Stabilization of Peptides

The Effect of Formulation Excipients on Leachables for IV-Administered Products Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Extraction of a recombinant full-length NADPH-cytochrome P450 oxidoreductase from bacterial membranes: effect of detergents and additives

(PDF) Effect of Fatty Acid Composition in Polysorbate 80 on the Stability of Therapeutic Protein Formulations

Novel markers to track oxidative polysorbate degradation in pharmaceutical formulations

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches. - Abstract - Europe PMC

Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy. - Abstract - Europe PMC

Evaluation of a sensitive GC–MS method to detect polysorbate 80 in vaccine preparation - ScienceDirect

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches. - Abstract - Europe PMC

Structural and biochemical characterization of a novel thermophilic Coh01147 protease